PCK2 and fatty liver disease: These changes contributed to reducing hepatic steatosis and improving insulin sensitivity in this sex, as evidenced by the lower Srebp1c expression, the greater AKT activation, and the higher insulin-induced suppression of PEPCK activity observed compared to females.